A new study has revealed that sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy.
This is the first time a study evaluating the combination therapy, peginterferon and ribavirin, has identified sexual dysfunction as a side effect.
World Hepatitis Day 2009 - Am I Number 12?
World Hepatitis Day which falls on May 19th, 2009 assumes great importance as Hepatitis is far more prevalent than HIV or cancer and in contradiction awareness about the condition is poor.
Advertisement
As part of the study, 260 men treated with peginterferon alfa-2a and ribavirin completed self-administered questionnaires concerning sexual desire, sexual function - including erectile and ejaculatory function - and sexual satisfaction before, during and after treatment.
Before therapy, 37 percent of men reported at least some degree of impairment in sexual desire, while 44 percent reported dissatisfaction with their sexual life.
![Hepatitis C Related To Pancreatic Cancer Risk : Study]( "Hepatitis C Related To Pancreatic Cancer Risk : Study")
Exposure to Hepatitis C virus is found to increase the risk of cancer of the biliary tree, the bile carrying pathway between the liver and pancreas.
In addition, 22 percent reported impairment in erectile and 26 percent in ejaculatory function.
The average onset of sexual dysfunction appeared to be within four weeks of starting antiviral therapy, and many patients reported a gradual worsening over time.
At the end of therapy (24 or 48 weeks), an estimated 38 percent to 48 percent of men reported that overall sexual function was worse than before treatment. African Americans reported less impairment in sexual desire and satisfaction than Caucasian Americans during therapy.
While most components of sexual health evaluated in this study resolved within six months after the cessation of therapy, erectile and ejaculatory function remained slightly worse than before therapy in a proportion of men who received a full 48 weeks of treatment.
The study has been published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Source: ANI
LIN
Hepatitis C Related To Pancreatic Cancer Risk : Study
Exposure to Hepatitis C virus is found to increase the risk of cancer of the biliary tree, the bile carrying pathway between the liver and pancreas.
Advertisement
In addition, 22 percent reported impairment in erectile and 26 percent in ejaculatory function.
The average onset of sexual dysfunction appeared to be within four weeks of starting antiviral therapy, and many patients reported a gradual worsening over time.
At the end of therapy (24 or 48 weeks), an estimated 38 percent to 48 percent of men reported that overall sexual function was worse than before treatment. African Americans reported less impairment in sexual desire and satisfaction than Caucasian Americans during therapy.
While most components of sexual health evaluated in this study resolved within six months after the cessation of therapy, erectile and ejaculatory function remained slightly worse than before therapy in a proportion of men who received a full 48 weeks of treatment.
The study has been published in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Source: ANI
LIN
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Menīs Health News
Men can have adverse effects on erectile dysfunction due to prolonged space travel and high amounts of galactic cosmic radiation.
Diagnostic lipid markers for metabolic syndrome and SCFAs correlate with interleukin immunoexpression in benign hyperplasia prostate tissue.
A combination of decitabine that targets loss of the gene RB1 and DS-7300a that targets the B7-H3 receptors effectively reduces advanced prostate tumor growth.
Research reveals a robust association between insecticide exposure and decreased sperm concentration in adult men globally.
Impact of fathers' mental well-being on child development remains a relatively uncharted territory and is explored by a recent study.